Biomarkers for Parkinson’s disease and Alzheimer’s disease
<p>Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) represent the two most prevalent neurodegenerative diseases in the world, affecting 30 million and 5 million people, respectively. As populations age, the global burden of AD and PD will increase, resulting in significant societal and ec...
| Autore principale: | |
|---|---|
| Altri autori: | |
| Natura: | Tesi |
| Pubblicazione: |
2018
|